시장보고서
상품코드
1974464

헬스케어 제3자 물류 시장 분석과 예측(-2035년)

Healthcare Third-party Logistics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Solutions

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 426 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헬스케어 제3자 물류 시장은 2024년 2,346억 달러로 평가되었고, 2034년까지 4,924억 달러에 이르고, CAGR은 약 7.7%를 나타낼 전망입니다. 헬스케어 제3자 물류 시장은 의약품, 의료기기, 의료 장비 수송, 창고 보관, 유통 등 의료 분야에 특화된 아웃소싱 물류 서비스를 포함합니다. 이 시장은 비용 효율성, 규제 준수 및 세계 공급망의 복잡성에 대한 요구에 의해 견인되고 있습니다. 의료 분야에서는 배송의 정확성과 신뢰성이 요구되기 때문에 콜드체인 물류, 실시간 추적, 재고 관리의 진보가 매우 중요합니다.

헬스케어 제3자 물류 시장은 세계 관세, 지정 학적 위험 및 진화하는 공급망의 역학에 의해 형성되는 복잡한 환경을 항해하고 있습니다. 일본과 한국에서는 관세의 영향과 지정학적 불확실성을 줄이기 위해 기업이 탄력적인 공급망 전략에 대한 투자를 늘리고 있습니다. 중국은 자급 자족에 대한 주력을 강화하고 외국 기업에 대한 의존도를 줄이기 위해 국내 물류 능력 육성을 추진하고 있습니다. 대만은 전략적 입지와 물류 전문 지식에 의해 중요한 위치를 차지하고 있지만, 지역적인 긴장의 영향을 받기 쉬운 상태가 계속되고 있습니다. 의료 물류 분야는 세계적으로 견고한 성장을 이루고 있으며, 기술 혁신과 효율적인 의료 제공에 대한 수요 증가가 이를 견인하고 있습니다. 2035년까지 디지털 통합과 지속가능성에 초점을 맞춘 시장 발전이 예상됩니다. 중동 분쟁은 세계 에너지 가격에 압력을 가하고 있으며 간접적으로 물류 비용과 업무 안정성에 영향을 미칩니다.

시장 세분화
유형 콜드체인 물류, 비콜드체인 물류
제품 의약품, 의료기기, 생물학적 제제, 백신, 임상시험용 의약품, 일반 의약품, 영양 보조 식품
서비스 운송, 창고 보관, 재고 관리, 주문 처리, 포장, 통관 업무, 역물류
기술 자동 창고 시스템, 창고 관리 시스템, 운송 관리 시스템, 블록체인, IoT, AI 및 머신러닝, 로봇
구성요소 하드웨어, 소프트웨어, 서비스
신청 병원, 제약 회사, 바이오 의약품 기업, 임상 연구 기관
도입 형태 On-Premise, 클라우드 기반, 하이브리드
최종 사용자 의료 제공업체, 제약 제조업체, 생명 공학 회사, 물류 회사
솔루션 공급망 최적화, 재고 시각화, 리스크 관리, 컴플라이언스 관리

헬스케어 제3자 물류 시장은 의료 부문의 효율적인 공급망 솔루션에 대한 수요가 증가함에 따라 현저한 성장을 이루고 있습니다. 운송 서비스 분야는 성과면에서 주도적인 역할을 하고 있으며, 제품의 품질 유지에는 온도 관리 물류 및 전문 화물 서비스가 필수적입니다. 이 분야에서는 생물 제제와 백신에 대한 수요 증가에 따라 콜드체인 물류가 특히 중요시되고 있습니다.

창고 보관 부문도 이어져 의료 제품을 위한 안전하고 규정 준수를 준수하는 시설의 중요성을 돋보이게 합니다. 자동 창고 시스템을 포함한 고급 창고 솔루션은 비즈니스 효율성을 향상시키기 위해 주목을 받고 있습니다. 포장, 라벨 부착, 재고 관리 등 부가가치 서비스도 종합적인 물류 솔루션으로 시장 전환을 반영하여 필수 요소로 부상하고 있습니다.

IoT와 블록체인과 같은 디지털 기술의 통합은 물류 업무를 변화시켜 실시간 추적과 투명성을 향상시킵니다. 이 기술적 진보는 시장의 추가 성장을 가속할 전망입니다.

헬스케어 제3자 물류 시장에서는 주요 기업이 전략적인 가격 설정과 혁신적인 제품 투입을 통해 주도권을 다투고 시장 점유율에 역동적인 변화가 생기고 있습니다. 경쟁 구도는 비용 효율성과 서비스 제공 강화에 중점을 둡니다. 각 회사는 의료 제공업체의 진화하는 요구에 부응하기 위해 지속적으로 신제품을 투입하고 있습니다. 이 동향은 의료 제품의 적시적이고 안전한 배송을 보장하는 효율적인 물류 솔루션에 대한 수요 증가에 대한 대응입니다. 각 회사가 채택하는 가격 전략은 경쟁 우위를 유지하는 데 매우 중요합니다.

경쟁 벤치마킹 조사를 통해 주요 기업이 합병과 인수를 통해 능력 강화를 도모하는 매우 경쟁이 심한 환경이 밝혀졌습니다. 엄격한 의료 규제에 대한 준수가 의무화되어 있기 때문에 규제의 영향도 중요한 역할을 하고 있습니다. 이 컴플라이언스는 신규 진출기업의 사업 전략과 시장 진입에 영향을 미칩니다. 데이터 기반 분석을 통해 물류 분야에서 디지털 변환으로의 전환 동향이 높아지고 있으며 기술 도입이 주요 차별화 요인이 되고 있음이 부각되고 있습니다. 공급망 관리의 혁신과 IoT, AI 등의 선진 기술의 통합으로 시장은 성장의 기운이 높아지고 있습니다.

주요 동향과 촉진요인

헬스케어 제3자 물류 시장은 공급망의 복잡화와 의료 서비스의 세계화를 배경으로 견고한 성장을 이루고 있습니다. 특히 현저한 동향은 의약품 및 생물학적 제제의 효능을 유지하기 위해 필수적인 온도 관리 물류 수요 증가를 포함합니다. 이 추세는 제조부터 사용 시점까지 제품의 무결성을 보장하는 고급 콜드체인 솔루션의 중요성을 강조합니다.

또한 IoT와 블록체인과 같은 기술 혁신은 물류 업무를 변화시켜 투명성과 추적성을 향상시키고 있습니다. 이러한 혁신 기술은 실시간 모니터링을 가능하게 하여 위조품 및 컴플라이언스 위반의 위험을 줄입니다. 또 다른 추진 요인은 비용 효율성과 비즈니스 최적화에 대한 관심 증가입니다. 의료 제공업체는 핵심 업무에 집중하고 환자 관리를 개선하기 위해 물류 업무를 타사 전문가에게 아웃소싱하는 경향이 커지고 있습니다.

또한, 지역별 규제의 복잡성으로 인해 전문적인 물류 솔루션이 필요하며, 기업은 세계 전문 지식을 갖춘 제3자물류 파트너를 추구하고 있습니다. 의료 분야에서의 전자상거래의 상승도 중요한 동향이며, 소비자는 의료용품과 의료기기의 보다 신속한 배송을 기대하고 있습니다. 의료 산업의 다면적 요구에 대응할 수 있는 통합 서비스를 제공하는 물류 사업자에게는 많은 기회가 존재합니다. 시장이 진화하는 동안 이러한 동향에 혁신과 적응을 도모하는 기업이 경쟁 우위를 확보할 것입니다.

억제와 도전

헬스케어 제3자 물류 시장은 몇 가지 심각한 제약과 문제에 직면하고 있습니다. 주요 과제 중 하나는 엄격한 규제 환경이며 다양한 국제 표준을 준수해야 하며 업무를 복잡하게 할 수 있습니다. 또한, 온도 관리가 필요한 의약품을 위한 콜드체인 물류를 유지하기 위한 높은 비용은 제3자물류 공급자에게 재정적인 부담이 됩니다. 또한 복잡한 의료 물류를 효율적으로 관리할 수 있는 숙련 노동력 부족도 시장 성장 억제요인입니다. 또 다른 과제는 기밀성이 높은 의료 데이터의 무결성과 기밀성을 위협하는 사이버 보안 위협 증가입니다. 마지막으로, 의료 기술의 진화 상황은 지속적인 적응과 투자를 필요로 하고, 자원을 압박하고, 신속한 시장 대응을 방해할 수 있습니다. 이러한 요인들이 함께 시장의 성장 가능성과 업무 효율성에 영향을 미치는 큰 장벽을 형성하고 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

  • 거시경제 분석
  • 시장 동향
  • 시장 성장 촉진요인
  • 시장 기회
  • 시장 성장 억제요인
  • CAGR : 성장 분석
  • 영향 분석
  • 신흥 시장
  • 기술 로드맵
  • 전략적 프레임워크

제4장 부문 분석

  • 시장 규모 및 예측 : 유형별
    • 콜드체인 물류
    • 비콜드체인 물류
  • 시장 규모 및 예측 : 제품별
    • 의약품
    • 의료기기
    • 생물학적 제형
    • 백신
    • 임상시험용 의약품
    • 일반의약품
    • 뉴트라슈티컬
  • 시장 규모 및 예측 : 서비스별
    • 교통기관
    • 창고 보관
    • 재고 관리
    • 주문 이행
    • 포장
    • 통관 업무
    • 역물류
  • 시장 규모 및 예측 : 기술별
    • 자동 창고 시스템
    • 창고 관리 시스템
    • 운송 관리 시스템
    • 블록체인
    • IoT
    • 인공지능(AI) 및 머신러닝
    • 로보틱스
  • 시장 규모 및 예측 : 구성요소별
    • 하드웨어
    • 소프트웨어
    • 서비스
  • 시장 규모 및 예측 : 용도별
    • 병원
    • 제약기업
    • 바이오의약품기업
    • 임상연구기관
  • 시장 규모 및 예측 : 전개별
    • On-Premise
    • 클라우드 기반
    • 하이브리드
  • 시장 규모 및 예측 : 최종사용자별
    • 의료 제공업체
    • 제약 제조업체
    • 바이오테크놀러지 기업
    • 물류회사
  • 시장 규모 및 예측 : 솔루션별
    • 공급망 최적화
    • 재고 가시성
    • 리스크 관리
    • 컴플라이언스 관리

제5장 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카
  • 아시아태평양
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주
    • 대만
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 사하라 이남 아프리카
    • 기타 중동 및 아프리카

제6장 시장 전략

  • 수요 및 공급 격차 분석
  • 무역 및 물류상의 제약
  • 가격-비용-마진 추세
  • 시장 침투
  • 소비자 분석
  • 규제 개요

제7장 경쟁 정보

  • 시장 포지셔닝
  • 시장 점유율
  • 경쟁 벤치마킹
  • 주요 기업의 전략

제8장 기업 프로파일

  • Kuehne Nagel
  • DHL Supply Chain
  • CEVA Logistics
  • UPS Healthcare
  • DB Schenker
  • GEODIS
  • FedEx Supply Chain
  • Nippon Express
  • Agility Logistics
  • Panalpina
  • Expeditors International
  • XPO Logistics
  • Sinotrans
  • DSV
  • Yusen Logistics
  • Rhenus Logistics
  • Bollore Logistics
  • Kintetsu World Express
  • Hellmann Worldwide Logistics
  • GEFCO

제9장 당사에 대해서

SHW

Healthcare Third-party Logistics Market is anticipated to expand from $234.6 Billion in 2024 to $492.4 Billion by 2034, growing at a CAGR of approximately 7.7%. The Healthcare Third-party Logistics Market encompasses outsourced logistics services tailored for the healthcare sector, including transportation, warehousing, and distribution of pharmaceuticals, medical devices, and equipment. This market is driven by the need for cost efficiency, regulatory compliance, and the complexity of global supply chains. Advances in cold chain logistics, real-time tracking, and inventory management are pivotal as healthcare demands precision and reliability in delivery.

The Healthcare Third-party Logistics Market is navigating a complex landscape shaped by global tariffs, geopolitical risks, and evolving supply chain dynamics. In Japan and South Korea, firms are increasingly investing in resilient supply chain strategies to mitigate tariff impacts and geopolitical uncertainties. China's focus on self-reliance has intensified, fostering domestic logistics capabilities to reduce dependency on foreign entities. Taiwan's strategic location and expertise in logistics make it pivotal, yet it remains vulnerable to regional tensions. The healthcare logistics sector globally is experiencing robust growth, driven by technological advancements and increased demand for efficient healthcare delivery. By 2035, the market is expected to evolve with a focus on digital integration and sustainability. Middle East conflicts are exerting pressure on global energy prices, indirectly affecting logistics costs and operational stability.

Market Segmentation
TypeCold Chain Logistics, Non-Cold Chain Logistics
ProductPharmaceuticals, Medical Devices, Biologics, Vaccines, Clinical Trial Materials, Over-the-Counter Drugs, Nutraceuticals
ServicesTransportation, Warehousing, Inventory Management, Order Fulfillment, Packaging, Customs Brokerage, Reverse Logistics
TechnologyAutomated Storage and Retrieval Systems, Warehouse Management Systems, Transportation Management Systems, Blockchain, IoT, AI and Machine Learning, Robotics
ComponentHardware, Software, Services
ApplicationHospitals, Pharmaceutical Companies, Biopharmaceutical Companies, Clinical Research Organizations
DeploymentOn-Premise, Cloud-Based, Hybrid
End UserHealthcare Providers, Pharmaceutical Manufacturers, Biotechnology Companies, Logistics Companies
SolutionsSupply Chain Optimization, Inventory Visibility, Risk Management, Compliance Management

The Healthcare Third-party Logistics Market is experiencing significant growth, driven by the rising demand for efficient supply chain solutions in the healthcare sector. The transportation services segment leads in performance, with temperature-controlled logistics and specialized freight services being critical for maintaining product integrity. Within this segment, cold chain logistics is particularly prominent due to the increasing need for biologics and vaccines.

The warehousing and storage segment follows closely, highlighting the importance of secure and compliant facilities for healthcare products. Advanced warehousing solutions, including automated storage and retrieval systems, are gaining traction as they enhance operational efficiency. Value-added services, such as packaging, labeling, and inventory management, are also emerging as essential components, reflecting the market's shift towards comprehensive logistics solutions.

The integration of digital technologies, such as IoT and blockchain, is transforming logistics operations, providing real-time tracking and enhancing transparency. This technological advancement is expected to further propel market growth.

The Healthcare Third-party Logistics Market is witnessing dynamic shifts in market share, with major players vying for dominance through strategic pricing and innovative product launches. The market's competitive landscape is characterized by a focus on cost-efficiency and enhanced service delivery. Companies are continuously launching new products, which are designed to meet the evolving needs of healthcare providers. This trend is a response to the increasing demand for streamlined logistics solutions that ensure the timely and safe delivery of medical products. The pricing strategies employed by these companies are critical in maintaining their competitive edge.

Competition benchmarking reveals a highly competitive environment, with key players enhancing their capabilities through mergers and acquisitions. Regulatory influences play a significant role, as compliance with stringent healthcare regulations is mandatory. This compliance impacts operational strategies and market entry for new players. Data-driven insights highlight a growing trend towards digital transformation in logistics, with technology adoption being a key differentiator. The market is poised for growth, driven by innovations in supply chain management and the integration of advanced technologies such as IoT and AI.

Geographical Overview:

The Healthcare Third-party Logistics (3PL) market is witnessing remarkable growth across various regions, each offering unique opportunities. North America remains a dominant player, propelled by advanced healthcare infrastructure and a robust supply chain network. The region's emphasis on efficient logistics solutions and regulatory compliance further accelerates market expansion.

In Europe, the market is thriving due to increased demand for specialized logistics services, particularly in pharmaceutical and biotechnology sectors. The region's focus on sustainability and innovation enhances its competitive edge. Asia Pacific emerges as a lucrative growth pocket, driven by rapid urbanization and rising healthcare investments.

Countries like China and India are at the forefront, with expanding healthcare facilities necessitating efficient logistics support. Latin America and the Middle East & Africa are also showing promising potential. Brazil and South Africa lead these regions, with growing healthcare needs and improving infrastructure contributing to market growth. These emerging markets offer significant opportunities for investment and expansion.

Recent Developments:

The healthcare third-party logistics market has been dynamic with significant developments over the past three months. DHL Supply Chain, a leader in logistics, announced a strategic partnership with a prominent pharmaceutical company to enhance its cold chain logistics capabilities, ensuring the safe and efficient transport of temperature-sensitive products.

UPS Healthcare expanded its logistics network by acquiring a state-of-the-art facility in the Netherlands, aimed at bolstering its European footprint and improving service delivery for healthcare clients. This acquisition is set to streamline operations and cater to the increasing demand for healthcare logistics in the region.

FedEx has introduced an innovative tracking technology for its healthcare logistics services, enhancing visibility and security for sensitive shipments. This technology aims to mitigate risks and ensure compliance with stringent regulatory standards in the healthcare sector.

In a move to strengthen its market position, Kuehne+Nagel formed a joint venture with a leading digital health company to integrate digital solutions into its logistics operations, offering clients enhanced data analytics and operational efficiency.

The healthcare logistics market witnessed a regulatory update with the European Union implementing new guidelines for the transportation of medical supplies, emphasizing the need for compliance with temperature control and documentation standards, which is expected to impact logistics providers across the continent.

Key Trends and Drivers:

The Healthcare Third-party Logistics Market is experiencing robust growth, driven by the increasing complexity of supply chains and the globalization of healthcare services. A significant trend is the rising demand for temperature-controlled logistics, essential for preserving the efficacy of pharmaceuticals and biologics. This trend underscores the importance of advanced cold chain solutions, ensuring product integrity from production to the point of use.

Moreover, technological advancements, such as IoT and blockchain, are transforming logistics operations, enhancing transparency and traceability. These innovations facilitate real-time monitoring, reducing the risk of counterfeiting and non-compliance. Another driver is the growing emphasis on cost efficiency and operational optimization. Healthcare providers are increasingly outsourcing logistics to third-party experts to focus on core competencies and improve patient care.

Furthermore, regulatory complexities in different regions necessitate specialized logistics solutions, prompting companies to seek third-party logistics partners with global expertise. The rise of e-commerce in healthcare is also a key trend, with consumers expecting faster delivery of medical supplies and devices. Opportunities abound for logistics providers offering integrated services, capable of navigating the multifaceted demands of the healthcare industry. As the market evolves, companies that innovate and adapt to these trends will secure a competitive advantage.

Restraints and Challenges:

The Healthcare Third-party Logistics Market encounters several significant restraints and challenges. A primary challenge is the stringent regulatory environment, which requires compliance with diverse international standards and can complicate operations. Additionally, the high costs associated with maintaining cold chain logistics for temperature-sensitive pharmaceuticals pose financial burdens on third-party logistics providers. Moreover, the market is constrained by the scarcity of skilled workforce capable of managing complex healthcare logistics efficiently. Another challenge is the increasing cybersecurity threats, which jeopardize the integrity and confidentiality of sensitive healthcare data. Lastly, the evolving landscape of healthcare technologies necessitates continuous adaptation and investment, which can strain resources and impede swift market responses. These factors collectively create substantial barriers, impacting the market's growth potential and operational efficiency.

Key Companies:

Kuehne Nagel, DHL Supply Chain, CEVA Logistics, UPS Healthcare, DB Schenker, GEODIS, FedEx Supply Chain, Nippon Express, Agility Logistics, Panalpina, Expeditors International, XPO Logistics, Sinotrans, DSV, Yusen Logistics, Rhenus Logistics, Bollore Logistics, Kintetsu World Express, Hellmann Worldwide Logistics, GEFCO

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Cold Chain Logistics
    • 4.1.2 Non-Cold Chain Logistics
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Pharmaceuticals
    • 4.2.2 Medical Devices
    • 4.2.3 Biologics
    • 4.2.4 Vaccines
    • 4.2.5 Clinical Trial Materials
    • 4.2.6 Over-the-Counter Drugs
    • 4.2.7 Nutraceuticals
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Transportation
    • 4.3.2 Warehousing
    • 4.3.3 Inventory Management
    • 4.3.4 Order Fulfillment
    • 4.3.5 Packaging
    • 4.3.6 Customs Brokerage
    • 4.3.7 Reverse Logistics
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Automated Storage and Retrieval Systems
    • 4.4.2 Warehouse Management Systems
    • 4.4.3 Transportation Management Systems
    • 4.4.4 Blockchain
    • 4.4.5 IoT
    • 4.4.6 AI and Machine Learning
    • 4.4.7 Robotics
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Pharmaceutical Companies
    • 4.6.3 Biopharmaceutical Companies
    • 4.6.4 Clinical Research Organizations
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 On-Premise
    • 4.7.2 Cloud-Based
    • 4.7.3 Hybrid
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Healthcare Providers
    • 4.8.2 Pharmaceutical Manufacturers
    • 4.8.3 Biotechnology Companies
    • 4.8.4 Logistics Companies
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Supply Chain Optimization
    • 4.9.2 Inventory Visibility
    • 4.9.3 Risk Management
    • 4.9.4 Compliance Management

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Kuehne Nagel
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 DHL Supply Chain
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 CEVA Logistics
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 UPS Healthcare
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 DB Schenker
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 GEODIS
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 FedEx Supply Chain
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Nippon Express
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Agility Logistics
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Panalpina
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Expeditors International
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 XPO Logistics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Sinotrans
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 DSV
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Yusen Logistics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Rhenus Logistics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Bollore Logistics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Kintetsu World Express
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hellmann Worldwide Logistics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 GEFCO
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제